Publicações científicas

Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer

Catalán V [ES] (1,2,3), Gómez-Ambrosi J [ES] (1,2,3), Rodríguez A [ES] (1,2,3), Ramírez B (1,2,3), Izaguirre M (1,2), Hernández-Lizoain JL (4), Baixauli J [ES] (4), Martí P [ES] (4), Valentí V (2,3,4), Moncada R (2,3,5), Silva C [ES] (2,3,6), Salvador J (2,6), Frühbeck G (1,2,3,6).
(1) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
(2) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
(3) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA) Pamplona, Spain.
(4) Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
(5) Department of Anesthesia, Clínica Universidad de Navarra, Pamplona, Spain.
(6) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain 

Revisão:PLoS One

Data: 9/Set/2016

Cirurgia Geral e Digestiva Anestesia e Cuidados Intensivos [ES] Endocrinologia e Nutrição [ES] Área de Obesidade

BACKGROUND:
Excess adipose tissue represents a major risk factor for the development of colon cancer with inflammation and extracellular matrix (ECM) remodeling being proposed as plausible mechanisms.

The aim of this study was to investigate whether obesity can influence circulating levels of inflammation-related extracellular matrix proteins in patients with colon cancer (CC), promoting a microenvironment favorable for tumor growth.

METHODS:
Serum samples obtained from 79 subjects [26 lean (LN) and 53 obese (OB)] were used in the study. Enrolled subjects were further subclassified according to the established diagnostic protocol for CC (44 without CC and 35 with CC). Anthropometric measurements as well as circulating metabolites and hormones were determined.

Circulating concentrations of the ECM proteins osteopontin (OPN), chitinase-3-like protein 1 (YKL-40), tenascin C (TNC) and lipocalin-2 (LCN-2) were determined by ELISA.

RESULTS:
Significant differences in circulating OPN, YKL-40 and TNC concentrations between the experimental groups were observed, being significantly increased due to obesity (P<0.01) and colon cancer (P<0.05). LCN-2 levels were affected by obesity (P<0.05), but no differences were detected regarding the presence or not of CC. A positive association (P<0.05) with different inflammatory markers was also detected.

CONCLUSIONS:
To our knowledge, we herein show for the first time that obese patients with CC exhibit increased circulating levels of OPN, YKL-40 and TNC providing further evidence for the influence of obesity on CC development via ECM proteins, representing promising diagnostic biomarkers or target molecules for therapeutics.

CITAÇÃO DO ARTIGO  PLoS One. 2016 Sep 9;11(9):e0162189. doi: 10.1371/journal.pone.0162189

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra